Follow Us:
Cefazolin Exporter From India

Cefazolin

Cefazolin is a first-generation cephalosporin antibiotic used to treat susceptible bacterial infections and prevent surgical-site infections during selected surgical procedures. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial death. Cefazolin may be used for infections involving the skin and soft tissues, bones and joints, respiratory tract and urinary tract, depending on bacterial susceptibility and the applicable product approval. It is supplied as a powder for injection and administered intravenously or, with suitable formulations, intramuscularly under medical supervision. Common side effects include nausea, vomiting, diarrhoea and injection-site reactions. Important precautions include the risk of severe allergic reactions, antibiotic-associated colitis and seizures in patients with significant kidney impairment.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Cefazolin

Cefazolin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Cefazolin

Availability of Cefazolin

Delivery of Cefazolin

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Cefazolin.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Cefazolin.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefazolin, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Cefazolin Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Cefazolin

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Cefazolin Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefazolin, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Cefazolin

The export of Cefazolin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Cefazolin Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Cefazolin specifications, certificates of analysis, and other supporting documents required for Cefazolin export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Cefazolin export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Cefazolin regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Cefazolin documentation, labelling, Cefazolin manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Cefazolin Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cefazolin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.